Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer.
about
Non-surgical interventions for late rectal problems (proctopathy) of radiotherapy in people who have received radiotherapy to the pelvisA comparison of robotic arm versus gantry linear accelerator stereotactic body radiation therapy for prostate cancerEvolving Paradigm of Radiotherapy for High-Risk Prostate Cancer: Current Consensus and Continuing ControversiesFiducial markers and spacers in prostate radiotherapy: current applicationsExternal beam radiotherapy for localized prostate cancerProton therapy for early stage prostate cancer: is there a case?Retreatment for prostate cancer with stereotactic body radiation therapy (SBRT): Feasible or foolhardy?Prospective randomized phase 2 trial of intensity modulated radiation therapy with or without oncolytic adenovirus-mediated cytotoxic gene therapy in intermediate-risk prostate cancerControversies in the treatment of high-risk prostate cancer--what is the optimal combination of hormonal therapy and radiotherapy: a review of literature.Efficacy and toxicity of external-beam radiation therapy for localised prostate cancer: a network meta-analysisComparative efficacy and safety of treatments for localised prostate cancer: an application of network meta-analysis.Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/american college of radiology 95-09Radiation therapy in prostate cancer: a risk-adapted strategy.Androgen deprivation therapy for prostate cancer-review of indications in 2010Transitioning from conventional radiotherapy to intensity-modulated radiotherapy for localized prostate cancer: changing focus from rectal bleeding to detailed quality of life analysisProspective evaluation of a hydrogel spacer for rectal separation in dose-escalated intensity-modulated radiotherapy for clinically localized prostate cancer.Early detection of Lewis lung carcinoma tumor control by irradiation using diffusion-weighted and dynamic contrast-enhanced MRI.Proctitis following stereotactic body radiation therapy for prostate cancerSystematic review: anal and rectal changes after radiotherapy for prostate cancer.High dose versus conventional dose in external beam radiotherapy of prostate cancer: a meta-analysis of long-term follow-up.Long-term results of a study using individualized planning target volumes for hypofractionated intensity-modulated radiotherapy boost for prostate cancer.The impact of increasing dose on overall survival in prostate cancer.Final Report of the Intergroup Randomized Study of Combined Androgen-Deprivation Therapy Plus Radiotherapy Versus Androgen-Deprivation Therapy Alone in Locally Advanced Prostate CancerThe impact of financial interest in intensity-modulated radiation therapy on the utilization of radiation therapy for treatment of newly diagnosed prostate cancer: a single center experienceClinical outcome of patients treated with 3D conformal radiation therapy (3D-CRT) for prostate cancer on RTOG 9406.Radiation treatment for patients with intermediate-risk prostate cancer.Correlation between patients' anatomical characteristics and interfractional internal prostate motion during intensity modulated radiation therapy for prostate cancer.Radiation therapy to the primary tumor in locally advanced prostate cancer is not "closing the barn door after the horse has bolted".Radiation dose-volume effects of the urinary bladder.Significant association of brachytherapy boost with reduced prostate cancer-specific mortality in contemporary patients with localized, unfavorable-risk prostate cancer.Randomised pilot study of dose escalation using conformal radiotherapy in prostate cancer: long-term follow-upMolecularly targeted agents as radiosensitizers in cancer therapy--focus on prostate cancer.Rectal endoscopy findings following stereotactic body radiation therapy for clinically localized prostate cancer.Treatment and Mortality in Men with Localized Prostate Cancer: A Population-Based Study in California.Toxicity and Long-Term Outcomes of Dose-Escalated Intensity Modulated Radiation Therapy to 74Gy for Localised Prostate Cancer in a Single Australian Centre.Radiotherapy and Hormone Treatment in Prostate CancerThe Comparison of Stereotactic Body Radiation Therapy and Intensity-Modulated Radiation Therapy for Prostate Cancer by NCCN Risk Groups.Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer.Systematic review of hypofractionated radiation therapy for prostate cancer.Prostate Cancer Radiation Therapy: What Do Clinicians Have to Know?
P2860
Q24185868-7C517156-62C6-4B35-AAC3-CE34731AEBF2Q26738278-E5026C1E-0DC5-4AFF-AEBA-08AA1ABD424BQ26744606-C542BD57-7A32-401B-A896-E1EA0D2A5A52Q26828469-2FCAAB95-7A4B-4A77-A838-27F59C4EEDCBQ26853068-740BED94-BA09-4EA8-86B4-CEB2C1F02599Q28072657-070AA50B-38A7-45A0-BC95-CF78677E62F9Q28081451-72106E3A-3710-4ED2-8237-D14C6436DB65Q33415382-DF949BB3-3721-45E0-91CC-97CAD33F8FD2Q33519113-C364E94C-1A0F-4BB1-A2C0-35A7F6D2C362Q33613683-2AF81340-9634-4D9A-A353-3075CFA61BE5Q33626084-0831064A-55A5-44CA-8F9B-75900CF0719DQ33710935-8F17CB06-12E9-4A53-A38A-C1BEF45214B4Q34111590-0B140266-DDEB-499A-BBF3-FF35EF380F34Q34111603-8CDB5903-B591-457B-AAD4-AF59FB2A4983Q34500966-B2A369E3-167E-4FB2-BD1B-305530A4DAA2Q34556112-9B735939-E5F5-45DA-9E46-ED925DA27846Q34712745-3A1CAB3B-019B-47D1-8544-F897E04BA950Q34748877-AD2E9E0B-D8EC-47F2-BC17-F333C1772856Q35024218-31C6E146-C648-4101-B185-E8EC6FF0ABF1Q35235550-7AFB83AE-C9D8-407B-AB7C-0B9BCDD4BB1CQ35530488-03EC658C-23CB-4D1C-811A-A04543507CB7Q35663315-9900FA02-AAC1-4A83-B51D-1AB564E10204Q35771166-35317CFB-45A6-456C-93B0-9B93C8488C8EQ35898128-292C193F-EC0E-4090-8289-BE76BC87BCCFQ35992601-76FC0268-CA5A-4113-AF19-23812D43B28BQ35992830-917D91A2-D1D4-4060-ABEF-0CC676246D3FQ36234065-5B9E0840-926F-4E0D-B58A-E55D900F5081Q36241918-EF768C7C-2045-45FF-85ED-50C7A237C3A9Q36655284-EF56AE97-FE26-487F-B3CE-E9D5774C372CQ36802277-40282092-AD68-4820-A02A-14E8696197BCQ37081939-31E7BC24-A856-494B-8EBF-6646D50B7232Q37092020-7BB9D650-5049-41A8-87C6-7A6CDB618364Q37116581-A979AE68-0F15-4452-95FC-8991957EE279Q37134562-FD56D197-ECD6-42D0-8860-16F51EA11C5CQ37137423-5C23B4FE-6EC3-4658-B541-53C7EA3B1182Q37176612-B97C710F-1804-4575-B0C2-9DE2F5E6F436Q37195789-B132B180-C53E-43BB-9970-0E9240A1045DQ37249348-5EC7CB37-EBCF-4260-97D3-7B6EA5A0039EQ37324126-BC59F2DF-A088-4C1B-A150-F8566DED28AAQ37578562-40E3DE3E-036E-4F25-BE48-04749705EC4F
P2860
Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Update of Dutch multicenter do ...... for localized prostate cancer.
@ast
Update of Dutch multicenter do ...... for localized prostate cancer.
@en
Update of Dutch multicenter do ...... for localized prostate cancer.
@nl
type
label
Update of Dutch multicenter do ...... for localized prostate cancer.
@ast
Update of Dutch multicenter do ...... for localized prostate cancer.
@en
Update of Dutch multicenter do ...... for localized prostate cancer.
@nl
prefLabel
Update of Dutch multicenter do ...... for localized prostate cancer.
@ast
Update of Dutch multicenter do ...... for localized prostate cancer.
@en
Update of Dutch multicenter do ...... for localized prostate cancer.
@nl
P2093
P1476
Update of Dutch multicenter do ...... for localized prostate cancer.
@en
P2093
Abrahim Al-Mamgani
Annerie Slot
Geert J L H van Leenders
Joos V Lebesque
Luca Incrocci
Michel F H Dielwart
Wilma D Heemsbergen
Wim L J van Putten
P304
P356
10.1016/J.IJROBP.2008.02.073
P407
P577
2008-05-19T00:00:00Z